Evidence map›Paper›PMID 40012228›Full record

ArticleBiology of the cell2025

Effects of lipid membranes on RNA catalytic activity and stability.

Tomasz Czerniak, James P Saenz

Abstract read
In one paragraph

Article in Biology of the cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. On an RNA-Membrane Protogenome.Life (Basel, Switzerland) · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tomasz CzerniakB CUBE Center for Molecular Bioengineering, Technische Universität Dresden, Dresden, Germany.ORCID https://orcid.org/0000-0003-2191-6205
James P SaenzB CUBE Center for Molecular Bioengineering, Technische Universität Dresden, Dresden, Germany.ORCID https://orcid.org/0000-0001-8901-4377

Funding

Bundesministerium für Bildung und ForschungGerman Federal Ministry of Education and Research BMBF 03Z22EN12Volkswagen FoundationVW Foundation 93090
6 · The paper itself

Abstract

backgound informationRNA plays crucial roles in cellular organization and metabolism, and modulating its activity is essential for maintaining cellular functions. RNA activity, involving both catalytic (ribozymes) and translation processes, is controlled via myriad mechanisms involving different binding partners such as proteins and smaller polar solutes. We previously reported that lipid membranes can directly interact with the artificial R3C ribozyme changing its activity, however, the effect of lipids on naturally occurring ribozymes remains unknown.

resultsHere, we report that both catalytic activity as well as RNA integrity can be controlled by the presence of different lipid membranes. Gel-phase lipid membranes decreased the activity of hepatitis delta virus ribozyme and increased the activity of a hammerhead ribozyme. The presence of lipid liquid membrane surfaces triggered RNA degradation with greater degradation occurring in the single-stranded regions of RNA.

conclusionThe interplay between RNA activity and stability in the presence of different lipid membranes introduces multiple possibilities, where different combinations of ribozyme and lipid membrane composition could produce different effects on activity. SIGNIFICANCE: Taken together, these observations support the hypothesis that the activity of both natural and artificial RNAs can be modulated by lipid membranes which, in turn, provides a foundation for the development of novel riboswitch-like molecules, and lipid membrane-based RNA-biosensors.

Indexed as

Membrane LipidsRNA, CatalyticRNA StabilityCatalysisHepatitis Delta Virushammerhead ribozymeMembrane LipidsRNA, Catalytic

Identifiers

PMID40012228
PMCPMC11865690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.